Quinine Side Effects

by

QUESTION

What are the side effects of quinine?

ANSWER

The main side effect of quinine, in therapeutic doses, is cinchonism or quinism. This is a condition associated with a number of symptoms, including flushed/sweaty skin, tinnitus, confusion, headaches, and more.

Mild cinchonism should not be a reason to cease treatment with quinine, however. If injected into a nerve, quinine can cause paralysis, and is an extremely potent poison if overdosed. In some cases, quinine can lead to constipation, erectile dysfunction and/or diarrhea. There are few side effects associated with oral quinine.

If you have taken medications for malaria, please help Malaria.com by taking our Malaria Medication Side-effects Survey: Treatment and Prophylaxis. Thank you!

Malaria Cure

by

QUESTION

What is the cure for malaria?

ANSWER

Malaria can be cured with a number of different medications, depending on then type of malaria and how far the disease has been progressed.

For standard, non-complicated Plasmodium falciparum malaria, the World Health Organisation recommends use of artemisinin-based combination therapies (ACTs), such as Coartem. This is due to increasing levels of resistance to chloroquine in many parts of the world. Indeed, even though chloroquine is still used in many places as first-line treatment against P. vivax, P. malariae, P. ovale and P. knowlesi uncomplicated malaria, there is some evidence that resistance to this treatment is also emerging, for example in P. vivax in parts of south-east Asia.

In cases where malaria infection has progressed to a stage where oral administration of medication is not possible, or where cerebral symptoms are suspected, the usual treatment option is intravenous quinine.

In addition, P. vivax and P. ovale malaria parasites are able to produce forms (called hypnozoites) which can become dormant in liver hepatocyte cells after the blood stages of the infection have been cleared. These dormant forms can become reactivated weeks or even months or years after the initial infection, which is called a “relapse” of the infection. One drug, called primaquine, is able to kill these liver stages, and so patients with either of these types of malaria should also discuss the possibility of taking primaquine.

Apart from these first-line treatments, there are other medications which are used against malaria, both prophylactically as well as for treatment. These include orally-administered quinine, pyrimethamine, mefloquine, proguanil, atovaquone and sulfonamides.

For more information, see the WHO recommendations for malaria treatment.


Injections for Malaria Treatment?

by

QUESTION

I have a friend that just told me that she has Malaria. She said she has to go to the hospital every day for an injection for around the next 2 weeks. Is this a typical treatment. Why not just take pills? I`m just trying to wrap my head around this and understand the different treatments.

ANSWER

This is certainly not typical treatment for malaria. Uncomplicated malaria is usually treated with oral medication, and the type depends on the type of malaria you have. The most severe form of malaria, Plasmodium falciparum, is often resistant to chloroquine (still the first-line drug of choice for P. malariae, P. knowlesi and P. ovale infections, as well as for P. vivax in most parts of the world) and so first-line treatment is now usually an artemisinin-based combination therapy (ACT), such as Coartem.

As far as I am aware, it is only in cases of complicated, severe malaria that intravenous or intramuscular treatment is used (usually quinine), and in those cases, treatment would not be administered on an outpatient basis. It may be that your friend has a specific medical requirement for a non-oral form of medication, but it is definitely unusual!

Discovery of Cinchona

by

QUESTION

Cinchona was discovered in which country?

ANSWER

“Cinchona” refers to a genus of trees which are known for having strong alkaloid compounds in their bark, and notably one which has anti-malarial properties.

This particular alkaloid is now known as “quinine.” Cinchona trees are native to South America, and were long used by native people to treat fevers—as such, it is perhaps impossible to ever know exactly where the bark of these trees was first used as a medicine.

The first records of its use come from after the Spanish conquest of South America; as legend has it, the Countess of Chinchón, who was the wife of the Viceroy of Peru in Lima, was the first European to be treated with the bark of a particular tree to cure a malaria infection, in the 1640s. She survived, and apparently brought the tree back with her to Europe, where its use against malaria proliferated as Europeans explored and colonized tropical regions throughout the world.

How is Malaria Treated

by

QUESTION

How is malaria treated?

ANSWER

This answer is copied from an earlier question about the various available cures for malaria.

Malaria can be cured with a number of different medications, depending on then type of malaria and how far the disease has been progressed.

For standard, non-complicated Plasmodium falciparum malaria, the World Health Organisation recommends use of artemisinin-based combination therapies (ACTs), such as Coartem. This is due to increasing levels of resistance to chloroquine in many parts of the world. Indeed, even though chloroquine is still used in many places as first-line treatment against P. vivax, P. malariae, P. ovale and P. knowlesi uncomplicated malaria, there is some evidence that resistance to this treatment is also emerging, for example in P. vivax in parts of south-east Asia.

In cases where malaria infection has progressed to a stage where oral administration of medication is not possible, or where cerebral symptoms are suspected, the usual treatment option is intravenous quinine.

In addition, P. vivax and P. ovale malaria parasites are able to produce forms (called hypnozoites) which can become dormant in liver hepatocyte cells after the blood stages of the infection have been cleared. These dormant forms can become reactivated weeks or even months or years after the initial infection, which is called a “relapse” of the infection. One drug, called primaquine, is able to kill these liver stages, and so patients with either of these types of malaria should also discuss the possibility of taking primaquine.

Apart from these first-line treatments, there are other medications which are used against malaria, both prophylactically as well as for treatment. These include orally-administered quinine, pyrimethamine, mefloquine, proguanil, atovaquone and sulfonamides.

 

How is Malaria Cured?

by

QUESTION

How is malaria cured?

ANSWER

Malaria can be cured with a number of different medications, depending on then type of malaria and how far the disease has been progressed.

For standard, non-complicated Plasmodium falciparum malaria, the World Health Organisation recommends use of artemisinin-based combination therapies (ACTs), such as Coartem. This is due to increasing levels of resistance to chloroquine in many parts of the world. Indeed, even though chloroquine is still used in many places as first-line treatment against P. vivax, P. malariae, P. ovale and P. knowlesi uncomplicated malaria, there is some evidence that resistance to this treatment is also emerging, for example in P. vivax in parts of south-east Asia.

In cases where malaria infection has progressed to a stage where oral administration of medication is not possible, or where cerebral symptoms are suspected, the usual treatment option is intravenous quinine.

In addition, P. vivax and P. ovale malaria parasites are able to produce forms (called hypnozoites) which can become dormant in liver hepatocyte cells after the blood stages of the infection have been cleared. These dormant forms can become reactivated weeks or even months or years after the initial infection, which is called a “relapse” of the infection. One drug, called primaquine, is able to kill these liver stages, and so patients with either of these types of malaria should also discuss the possibility of taking primaquine.

Apart from these first-line treatments, there are other medications which are used against malaria, both prophylactically as well as for treatment. These include orally-administered quinine, pyrimethamine, mefloquine, proguanil, atovaquone and sulfonamides.

For more information, see the WHO recommendations for malaria treatment.

History of Fighting Malaria

by

QUESTION

What are some examples of attempts of fighting this disease that happened in the past?

ANSWER

The battle against malaria has been going on, in one form or another, for literally thousands of years. The ancient Chinese mention the symptoms of the disease in a medical scroll as early as 2700 BCE – even more remarkably, a herb called Artemesia has been used in traditional Chinese medicine for more than 2000 years to treat malaria, and compounds extracted from that same herb are the basis for some of the most effective modern medications, known as artemisinin-based combination therapies (ACTs). Indigenous tribes in the Americas also had traditional medicines to treat malaria; having conquered the New World, the Spanish learned of a bark, from the Cinchona tree, which could cure malaria. Quinine, extracted from this same tree bark, is still used today to treat malaria.

However, back then the causes of malaria were not known—it wasn’t until the late 19th century that a more complete understanding of malaria would emerge. The first key development in this process was the observation of the parasites that cause malaria in a patient’s blood, which was first done by Charles Louis Alphonse Laveran in 1880.

A few years later, in 1897, a British army doctor called Ronald Ross discovered that the parasite was transmitted via the bite of infected mosquitoes, of the genus Anopheles. This latter finding allowed for the emergence of the first programmes for malaria control, which focused on vector control, through insecticide use and elimination of water bodies used by the mosquito larvae. An early example of the success of this approach came in the building of the Panama Canal; started in 1906, progress was initially slow, due to the enormous proportion of workers who fell ill from yellow fever and malaria. With vector control, the number of cases plummeted, and the canal was finally opened in 1914.

While prophylactic quinine had also been part of the control strategy during the building of the Panama Canal, it played a much more secondary role to vector control. Using similar strategies, focusing primarily on killing adult mosquitoes through insecticide spraying (mainly DDT), the United States of America successfully eliminated malaria from its shores in the early 1950s. Prior to this, transmission had occurred across most of the south-east of the country.

In the last 50 years, access to early diagnosis and effective treatment have gained a more prominent role among many malaria control strategies, although prevention is still seen as crucial. Many developing countries, where malaria is still rife, have set up national control programmes, which seek to ensure that all communities have access to adequate care and information about malaria prevention.

A key tool in the prevention arsenal has been the long-lasting insecticide treated bednet; sleeping underneath one prevents bites from the mosquitoes that carry malaria, which are most active in the evenings and at night, especially in children and pregnant women, who are among the people most at risk from infection. Bednet distribution has been a major focus of many malaria campaigns, and very successful in many places; in 2008, for example, bednet coverage was estimated at over 80% of the at-risk population in Djibouti, Mali, Ethiopia and Sao Tome and Principe.

Treatment for Malaria

by

QUESTION:

What is the main medicine to cure malaria and about safety precautions?

ANSWER:

There are a number of medicines used to treat malaria. Traditionally, chloroquine has been the first line drug of choice for uncomplicated, non-resistant malaria. However, several types of malaria, and most notably Plasmodium falciparum, the most severe and deadly kind, has become resistant to chloroquine in many places. In some parts of south-east Asia, Plasmodium vivax has also begun to show worrying signs of chloroquine resistance. In such settings, where resistance to chloroquine is suspected, the first line medications for uncomplicated cases are artemisinin-based combination therapies (ACTs), such as Coartem.

The World Health Organization has recommended that artemisinin only be given in combination with another drug to prevent malaria also becoming resistant to this therapy as well. Cases of malaria which have progressed beyond the grasp of that treatable with oral medication as described above (so-called “complicated” cases, most common with P. falciparum infection) are usually given intravenous quinine as a first-line response.

All of these treatments have been rigorously tested in strictly controlled clinical and field trials, and while they may have side effects, they are generally mild and in most cases, the patient will be given the dose without prior testing for reaction to the drug. One exception is with primaquine, which is sometimes used as a preventative medication against malaria and can also be used to treat the liver stages of P. vivax and P. ovale. Primaquine is known to cause severe haemolysis in people with G6DP deficiency, and so people with a high statistical probability of having this condition (for example due to family history or ethnicity) should be tested prior to being given primaquine.

Drugs for Malaria

by

QUESTION

What drugs are used in the treatment of malaria?

ANSWER

There are a number of medicines used to treat malaria. Traditionally, chloroquine has been the first line drug of choice for uncomplicated, non-resistant malaria. However, several types of malaria, and most notably Plasmodium falciparum, the most severe and deadly kind, has become resistant to chloroquine in many places. In some parts of south-east Asia, Plasmodium vivax has also begun to show worrying signs of chloroquine resistance. In such settings, where resistance to chloroquine is suspected, the first line medications for uncomplicated cases are artemisinin-based combination therapies (ACTs), such as Coartem.

The World Health Organization has recommended that artemisinin only be given in combination with another drug to prevent malaria also becoming resistant to this therapy as well. Cases of malaria which have progressed beyond the grasp of that treatable with oral medication as described above (so-called “complicated” cases, most common with P. falciparum infection) are usually given intravenous quinine as a first-line response.

All of these treatments have been rigorously tested in strictly controlled clinical and field trials, and while they may have side effects, they are generally mild and in most cases, the patient will be given the dose without prior testing for reaction to the drug. One exception is with primaquine, which is sometimes used as a preventative medication against malaria and can also be used to treat the liver stages of P. vivax and P. ovale. Primaquine is known to cause severe haemolysis in people with G6DP deficiency, and so people with a high statistical probability of having this condition (for example due to family history or ethnicity) should be tested prior to being given primaquine.

 

G6PD and Malaria

by

QUESTION:

Does one need to have a normal result in G6PD screening before he can take Malarial pills?

ANSWER:

In some cases, yes. When a patient has been diagnosed with Plasmodium ovale or Plasmodium vivax infection, in addition to medication such as chloroquine to target the blood stages of the parasite, an additional drug, called primaquine, may also be required. Primaquine kills the liver stages, known as hypnozoites, of these forms of malaria, preventing relapse of infection later on.

However, primaquine is known to cause severe haemolytic anaemia in people who are G6PD deficient. G6PD deficiency is restricted to certain populations or segments of populations; therefore it may be that not every person requiring primaquine will be tested for their G6PD status, only those considered high risk for potential deficiency. Patients with severe G6PD deficiency should not take primaquine; unfortunately at this stage there are no alternative drug regimens available. Patients with mild forms of G6PD deficiency should take primaquine at an alternative dose to G6PD-normal patients, usually 0.75mg/kg bodyweight once a week for 8 weeks (as opposed to 0.25mg/kg bodyweight once a day for 5 or 14 days, depending on the case history of the patient and the physician’s recommendation).

There is also some evidence that quinine can cause haemolysis in patients with G6PD deficiency; such patients may also have increased blood concentrations of mefloquine when taken concurrently with primaquine. As such, combinations of quinine or mefloquine with primaquine in G6PD-deficient patients is not recommended.